Physician Assistant, Medical · New York, NY
NPI
1396094587
Since 2012
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
139 Centre St, Suite 704
New York, NY, 10013
Phone (212) 219-8878
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,289
97 services
Medicare patients, 2024
63
Average age 72
Drug cost, 2024
$605K
3,540 prescriptions
Company payments, 2025
$5,310
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meiting Liang was code 99214 (office e&m - established), 52 times for 36 patients. In total Meiting Liang billed 97 services in 4 codes, and Medicare paid $8,289.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 52 | 36 | $93.15 | $4,844 |
| 99213 Office E&M - Established | Office | 34 | 27 | $65.88 | $2,240 |
By year: 2022 $8,498 for 100 services; 2023 $10K for 113 services; 2024 $8,289 for 97 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meiting Liang prescribed most often to Medicare patients was Omeprazole, with 686 prescriptions and refills. In total Meiting Liang wrote 3,540 Medicare prescriptions that cost $605K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 686 | 705 | 343 | $6,742 |
| Esomeprazole Magnesium Generic | 479 | 497 | 253 | $5,534 |
| Sucralfate Generic | 365 | 373 | 182 | $17K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 248 | 248 | 244 | $3,727 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 189 | 189 | 187 | $24K |
| Pantoprazole Sodium Generic | 174 | 176 | 95 | $767 |
| Famotidine Generic | 171 | 172 | 83 | $1,169 |
| Vemlidy Tenofovir Alafenamide | 156 | 156 | 27 | $217K |
| Dexlansoprazole Dr Dexlansoprazole | 155 | 166 | 76 | $24K |
| Linzess Linaclotide | 147 | 159 | 40 | $83K |
| Dicyclomine Hcl Generic | 102 | 102 | 78 | $867 |
| Procto-Med Hc Hydrocortisone | 64 | 65 | 37 | $636 |
| Hydrocortisone Generic | 62 | 62 | 35 | $936 |
| Creon Lipase/Protease/Amylase | 53 | 60 | 12 | $91K |
| Mesalamine Er Mesalamine | 42 | 46 | Under 11 | $5,190 |
Brand drugs: - claims; generic drugs: 2,695 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meiting Liang $5,310 ($5,310 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $3,524.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $3,524 |
| Gilead Sciences, Inc. GILD | 26 | $802 |
| Madrigal Pharmaceuticals MDGL | 10 | $460 |
| Janssen Biotech, Inc. JNJ | 11 | $230 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $106 |
| Aimmune Therapeutics, Inc. | 4 | $64.81 |
| Pfizer Inc. PFE | 3 | $62.49 |
| Intercept Pharmaceuticals, Inc. | 2 | $38.44 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $22.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.